Innovating antibodies, improving lives

Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.


Dec 9 260x1732019 R&D Update and ASH Data Review 

Genmab hosted its 2019 R&D Update and ASH Data Review on December 9. The event was webcast live. You can click here to listen to the replay and click here to download the presentation. 

This meeting was not an official program of the ASH Annual meeting.


join our team_260x173Career Opportunities at Genmab

Genmab is seeking new employees to join our team. Visit our Careers webpages to explore current vacancies, learn about our culture and meet some of our team members. Click here to visit Genmab's page on LinkedIn.    



Investorportal sign on_260x173InvestorPortal

To register your email address for electronic shareholder communication or to update your settings, log on to the InvestorPortal.


Latest news

Our Strategy

  • Click here to watch a video about our strategy.

Strategy Film

Stock Info